Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Avita Medical, Inc. - Common Stock (NQ:RCEL)

7.510 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Avita Medical, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
AVITA Medical Launches Cohealyx, Supporting Healing and Unlocking New Market Opportunity
From AVITA Medical
Via GlobeNewswire
What Analysts Are Saying About AVITA Medical Stock
Via Benzinga
AVITA Medical Announces Exclusive Manufacturing and Distribution Agreements with Stedical Scientific
From AVITA Medical
Via GlobeNewswire
Analyst Expectations For AVITA Medical's Future
Via Benzinga
Earnings Scheduled For February 13, 2025
Via Benzinga
AVITA Medical to Present at TD Cowen’s 45ᵗʰ Annual Health Care Conference
From AVITA Medical
Via GlobeNewswire
Stocks Mixed As Tariff-Focused Week Winds Down
Stocks are mixed as the week winds down, with the Dow Jones Industrial Average down triple digits, while the S&P 500 Index sits flat, and the Nasdaq Composite inches higher. 
Via Talk Markets
Topics Stocks Stocks / Equities
Exposures US Equities
Friday's session: gap up and gap down stocks
The market is filled with gapping stocks in Friday's session. Let's discover which stocks are showing gap-ups and gap-downs. 
Via Chartmill
AVITA Medical to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
AVITA Medical Reports Fourth Quarter and Full Year 2024 Financial Results
From AVITA Medical
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Avita Medical Cuts Annual Sales Forecast On Softer Demand From Hospitals
AVITA Medical revises 2024 revenue guidance to $64.3 million, citing year-end inventory adjustments, and forecasts 2025 revenue growth of 55%-65% with new product launches. 
Via Benzinga
AVITA Medical, Quantum Computing And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
AVITA Medical Updates Expected Fourth Quarter and Full Year 2024 Revenue, Provides 2025 Financial Guidance
From AVITA Medical
Via GlobeNewswire
This ServiceNow Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday
Via Benzinga
AVITA Medical Announces FDA Approval of RECELL GO mini, Optimizing Treatment for Smaller Wounds
From AVITA Medical
Via GlobeNewswire
AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable Market
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Present at the Piper Sandler 36ᵗʰ Annual Healthcare Conference
From AVITA Medical
Via GlobeNewswire
AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
AVITA Medical Reports Third Quarter Financial Results
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Announce Third Quarter 2024 Financial Results
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Present at 2024 Cantor Global Healthcare Conference
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Participate in Lake Street’s 8th Annual Best Ideas Growth (BIG8) Conference
From AVITA Medical
Via GlobeNewswire
RCEL Stock Earnings: AVITA Medical Misses EPS, Beats Revenue for Q2 2024
RCEL stock results show that AVITA Medical missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
AVITA Medical to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
AVITA Medical Reports Second Quarter Financial Results
From AVITA Medical
Via GlobeNewswire
AVITA Medical Names Robin VanDenburgh as SVP of U.S. Commercial Sales
From AVITA Medical
Via GlobeNewswire
AVITA Medical Expands Portfolio with Unique Dermal Matrix to Advance Wound Care
Exclusive development and distribution agreement with Regenity Biosciences provides AVITA Medical with the commercialization rights to a unique collagen-based dermal matrix following 510(k) clearance 
From AVITA Medical
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.